Email
Password
(Forgot Password?)
Most of the work of the Kentucky Tobacco and Health Research Institute has already been published by others. Most of the projects stipulate experimental models fo assumed association between smoking and disease, while some continue in spin off areas. On the other hand, Layton Davis and Fell are interested in the positive aspects of smoking.
By 1983, the anti-smoking lobby in Congress was unwilling to compromise with the Hatch/Packwood and Hatch bills on the floor. Eight issues relationg to cause, attribution, the format of warnings, addiction warning, tar, nicotine and CO disclosures, ingredients disclosure, the jurisdiction of the FTC, and preemption were identified as representing the greatest threats to the industry in the pending legislative proposals and lobbyists were instructed to attempt to maintain the status quo by coordinating efforts with legislative friends, particularly Senator Ford. No coordination occured and legislative friends were surprised. However, the bill adopted eliminates and modifies some of the threats paricularly those relating to cause, attribution, format of warning, addiction warning and tar, nicotine and CO disclosures.
In light of the smoking and health litigation in the US in which plaintiffs' lawyers are aggressive about questioning CEOs about publiched company statementson the basis of BAT publications intended for limited distribution the usual attention given to proposed BAT publications are justified. (45 comments are made suggesting alterations and deletion of statements and conclusions in the draft paper, rewriting passages, and deleting or not using some references.)
Document covers the tobacco company's position on smoking and health controversy. Presents quotes and highlights from research questioning the causality of diseases by smoking, and offers alternative theories to causation, including cancer. Argues that people will continue to smoke, and more research is needed into causes of diseases allegedly connected to smoking.
The CTR had a massive inhalation study led by Richard Kouri with Carol Henry which found no quamous cell carcinoma in the observed animals. Although the direct applicability of this work for a study of an inhalation study using a package of commonly added flavors, it may be useful.
Outlines the public issue environment over the coming 3 to 5 years. Of the current 32 pending tobacco cases of which 7 are against B&W, some are expected to go to trial and depending on their outcome to more litigation. B&W will strongly litigate each case. The BAT group has to mainitain its independence so as not to be brought into cases by plaintiffs' counsels. More restrictions and taxes are to be expected at both the federal and local governemntal levels, and the Congress may abolish the tobacco price suport program. Members of Congress may also make public disclosures made by the industry under the Comprehensive Education Act of 1984. B&W fac es a significant risk of financial loss in litigation and governmental restrictions. Marketing propositions offering benefits will in the long term pose risk for business as industry adversaries will be hostile to such claims. B&W documents during the planning period will be obtained by plaintiffs' lawyers and leaked to press. The litigation by Philip Morris is moving to trial and expected to lead to settlement.
A number of projects are identified from among the studies being conducted at the laboratories of affiliated companies in different countries from which B&W will recieve concise reports despite the risk that such reports may serve as road maps for plaintiffs' lawyers due to RD&E's interest.
Attached document on randon contamination should cast doubt about death attributable to cigarettes because there may double counting in the number of such deaths and because recent epidemological reports suggest a protective effect for smokers in relation to some diseases that may offset the number of deaths attributable to cigarttes.
Intent of letter of September 2, 1987, on which Jim Glenn and David Stone commented, was to point to anomalies in scientific literature that should lead to a revision of the notion that smoking is responsible for unchanging number of deaths. Thus, the letter did not deal with, among others, funding to CTR.
Document provides an indexed depostion of Robert K. Heimann. Discusses information concerning tobacco manufacturer's organizations such as CTR and TIRC, The Tobacco Institute, and Industry Technical Committee. Provides detailed information on the functioning of industry groups in relation to specific companies and the relationship between the tobacco companies. Describes specific research studies and sources of research for the industry.
Document contains a master list and text for all of the major press releases relating to American Tobacco Company from 1953 to 1983. Includes general public statements, such as "A Frank Statement to Cigarette Smokers," published articles appearing in magazines such as Time, scietific research press releases, and annual reports. Additionally, includes depositions from law suits.
Document contains a master list and text for all of the major press releases relating to American Tobacco Company from 1960 to 1983. Includes Annual Reports, press releases featuring recent industry-sponsored research, such as "Heavy Smokers and Low Mortality" (1962), public statements made by industry executives, and stockholder meeting statements.
Document provides complete text for all public statements made by American Brands concerning tobacco. Includes earnings reports, annual reports, senate hearings statements and press releases. Compiles statements from a 11 year period from 1972 to 1983, including statements relating to advertising, litigation, legislation and current research (smoking and health issues).
Document provides a table of contents for public statements of AB concerning tobacco. Topics listed include Addiction, Additives, Advertising, AMA, Animal Studies, Company Awareness of the claimed dangers of smoking, benefits of smoking, causation, cigarette design, TIRC, environmental cigarette smoke, the FCC, the FTC, Marketing, Nicotine, Prior litigation, publications regarding controversy, research, "safe cigarettes," statistics, tar, The Tobacco Institute, warning statements (adequacy, history, duty to warn). Types of statements included depositions, press releases, brochures and publications, and transcripts of statements made in front of congress.
Document provides deposition testimony of several witnesses in Green v. AT. Argues that nicotine is not addictive. One witness contends that "it would have a slight effect in terms of physiological response on stopping smoking, but that does not make it and addicting drug, or an addicting substance." Further states that an addicting substance indicates that the individual becomes dependant upon the presence of that material for normal functioning. Provides testimony from several witnesses to the same effect, arguing that while nicotine is habit-forming, it is not addictive.
Collection of excerpts form depositions, legislative hearings and letters.
Lists documents such as press releases, excerpts from depostions and legislative hearings and letters regarding additives. Includes assertions that new filters do not require additives; glycerine rather than Ethylene glycon has been used as an additive in Pall Malls; testimony before the House Committee on Interstate and Foreign Commerce explaining the difficulty of submitting information about additives to the Surgeon General. Provides excerpt of Kloepfer statement before the House hearings on Cigarette Labeling and Advertising (1969) regarding the terms under which research on Chemosol is to be conducted by the Hazelton Laboratories.
Lists documents containing statements of executives and scientists regarding animal experiments showing the connection between cigarettes and cancer.
Compiles several press releases on the topic of smoking and health. Focuses on the question of the causal relationship between lung cancer and cigarettes. Argues that there is no scientific evidence to show that smoking causes lung cancer (or heart disease). Points out many specific anomalies in the body of research.
Compiles excerpts from press releases, Congressional hearings, and depositions from Green v. AT (1959), Zagurski (1967), and Kraft (1973). Argues that there is no clinical or biological evidence that cigarettes cause disease, particularly lung cancer.
Compiles an outline of excerpts from annual reports, depositions (from Green and from Zagurski), congressional hearings, press releases, and statements regarding the public's awareness of the alleged dangers of cigarettes. Focuses on the idea that more labels and warnings are not necessary as virtually everyone is aware of the claimed dangers of smoking.
Compiles an outline of excerpts from depositions (from Green), congressional hearings, press releases, and statements regarding the benefits of smoking. Focuses on the ideas that tobacco has been used for centuries, has a huge demand, and provides people with relaxation and pleasure. Points out the large amount of revenue brought in by cigarette taxes.
Compiles an outline of excerpts from annual reports, depositions (from Green, 1959 and from Zagurski, 1967), congressional hearings, press releases, and statements regarding the relationship between cigarettes and lung cancer. Focuses on defending the idea that there is no scientific evidence to prove that smoking causes lung cancer. Points out problems with research that claims to prove a correlation and details research that finds contradictions. Contends that the health concerns regarding smoking are greatly exaggerated.
Compiles a table of contents and master index for a compilation of excerpts from annual reports, depositions (from Green and from Zagurski), congressional hearings, and press releases regarding AB's public statements on tobacco.
Compiles an outline of excerpts from depositions (from Green, from Zagurski, and from Kraft), congressional hearings, press releases, and statements regarding the Council for Tobacco Research (TIRC). Focuses on clarifying the origin, purpose, and scope of TIRC/CTR. Defends TIRC/CTR as an objective organization.
Compiles an outline of excerpts from press releases, depositions (from Green and from Kraft), and statements regarding prior litigation against tobacco companies. Provides details from several specific court cases regarding product liability.